Medicaid

Pharmalot

Mallinckrodt sues CMS over Medicaid rebates for its pricey Acthar Gel medicine

By Ed Silverman

Pharmalot

Seeking to contain drug costs, CMS may have ‘killed’ a PBM billing practice

By Ed Silverman

Pharmalot

Pharmalittle: Surprise FDA approval may dampen storm over pricey drug; should the U.S. adopt reference pricing?

By Ed Silverman

Pharmalot

Pharmalittle: Ending Medicare and Medicaid rebates will boost drug spending

By Ed Silverman

Pharmalot

Pharmalittle: FDA approves Sanofi dengue vaccine; Merck boosts measles vaccine production

By Ed Silverman

Pharmalot

State attorneys general sharply criticize a government task force over opioid prescribing

By Ed Silverman

Pharmalot

Pharmalittle: Allergan shareholders nix proposal to split CEO and chairman roles; FDA orders warnings for sleeping pills

By Ed Silverman

Biotech

MassBio’s push to soften state drug-price legislation produces plenty of drama

By Jon Chesto — Boston Globe

Pharmalot

Pharmalittle: Medicare proposes boosting payments for CAR-T drugs; Sacklers want to settle opioid suits

By Ed Silverman

Pharmalot

Lawmakers ask the Trump administration to investigate PBM pricing practices

By Ed Silverman

Pharmalot

Indivior charged with conducting multibillion-dollar fraud to boost opioid-treatment sales

By Ed Silverman

First Opinion

Health aides’ low wages threaten home health care, a necessity for millions

By David Totaro

First Opinion

Sen. Grassley: Stop kicking Medicaid’s safety net hospital payments down the road

By Chuck Grassley

Hospitals

CMS proposes changing requirements for less-invasive heart valve procedure

By Matthew Herper

Pharmalot

Kentucky probes pharmacy benefit managers for allegedly overcharging state Medicaid

By Ed Silverman

Pharmalot

Amid probe into PBMs, Ohio sues OptumRx for $16 million, and the AG says ‘there’s a storm a-comin’’

By Ed Silverman

Pharmalot

Patient advocacy groups in Canada with ties to pharma are big boosters for government coverage

By Ed Silverman

Pharmalot

Pharmalittle: Lilly to sell version of insulin at half price; senators push drug price gouging bill

By Ed Silverman

Pharmalot

Ohio seeks $16m from UnitedHealth’s PBM for overcharging on drugs

By Ed Silverman

Pharmalot

A big PBM wants drug makers to agree to rebate demands that would preserve its bottom line

By Ed Silverman and Ike Swetlitz

First Opinion

‘Cloud of secrecy’ in Medicare Advantage plans can create an environment for fraud

By Jeanne A. Markey and Raymond M. Sarola

Pharmalot

Washington state becomes the latest to embrace a Netflix model for buying hep C drugs

By Ed Silverman

Pharmalot

Pharmalittle: Senate committee ‘reinvites’ big drug makers to testify; can pharma use AI to solidify patents?

By Ed Silverman

First Opinion

We’re missing the true point of hospital price transparency

By Jay Deady

Pharmalot

Here’s how Massachusetts officials hope to lower their Medicaid drug spending

By Ed Silverman

Drug-pricing watchdog group is ‘mouse that roared’

Pharmalittle: Pfizer to buy Array for $11 billion, Teva settlement in Oklahoma may hit a new snag

5 names to know at Uber and Lyft: the key players behind ride-sharing’s move into health care

Pharmalittle: Lawmakers push bill to punish opioid execs; Novartis will have ‘enormous leverage’ pricing its SMA drug

Mallinckrodt sues CMS over Medicaid rebates for its pricey Acthar Gel medicine

Seeking to contain drug costs, CMS may have ‘killed’ a PBM billing practice

Pharmalittle: Surprise FDA approval may dampen storm over pricey drug; should the U.S. adopt reference pricing?

Pharmalittle: Ending Medicare and Medicaid rebates will boost drug spending

Pharmalittle: FDA approves Sanofi dengue vaccine; Merck boosts measles vaccine production

State attorneys general sharply criticize a government task force over opioid prescribing

Pharmalittle: Allergan shareholders nix proposal to split CEO and chairman roles; FDA orders warnings for sleeping pills

MassBio’s push to soften state drug-price legislation produces plenty of drama

Pharmalittle: Medicare proposes boosting payments for CAR-T drugs; Sacklers want to settle opioid suits

Lawmakers ask the Trump administration to investigate PBM pricing practices

Indivior charged with conducting multibillion-dollar fraud to boost opioid-treatment sales

Health aides’ low wages threaten home health care, a necessity for millions

Sen. Grassley: Stop kicking Medicaid’s safety net hospital payments down the road

CMS proposes changing requirements for less-invasive heart valve procedure

Kentucky probes pharmacy benefit managers for allegedly overcharging state Medicaid

Amid probe into PBMs, Ohio sues OptumRx for $16 million, and the AG says ‘there’s a storm a-comin’’

Patient advocacy groups in Canada with ties to pharma are big boosters for government coverage

Pharmalittle: Lilly to sell version of insulin at half price; senators push drug price gouging bill

Ohio seeks $16m from UnitedHealth’s PBM for overcharging on drugs

A big PBM wants drug makers to agree to rebate demands that would preserve its bottom line

‘Cloud of secrecy’ in Medicare Advantage plans can create an environment for fraud

Washington state becomes the latest to embrace a Netflix model for buying hep C drugs

Pharmalittle: Senate committee ‘reinvites’ big drug makers to testify; can pharma use AI to solidify patents?

We’re missing the true point of hospital price transparency

Here’s how Massachusetts officials hope to lower their Medicaid drug spending

Medicaid

Sign up for our Daily Recap newsletter